CHOP rolls out a powerful disease fighting weapon

Mark Abrams
October 31, 2018 - 7:03 pm
Dr. Beverly Davidson, chief scientific strategy officer at Children's Hospital of Philadelphia, stands in front of the Quality Control Lab in the new clinical manufacturing research complex off Civic Center Boulevard on the hospital campus.

Mark Abrams/KYW Newsradio


PHILADELPHIA (KYW Newsradio) — Children's Hospital of Philadelphia is promoting a new, state-of-the-art research facility which is conducting clinical trials for drugs to cure cancers and complex genetic and neurological diseases.

The hospital invested some $75 million dollars into the new research complex on its West Philadelphia campus and is in the process of opening its next phase, clinical manufacturing.

Dr. Beverly Davidson, chief scientific strategy officer, says breakthroughs are happening already.

"We're manufacturing drugs for today, tomorrow, and the future. And these drugs are really based on precision medicine and gene therapy. The kind of drug that will provide a lifetime of therapy from a simple one-time or only few-time infusion," she said.

Dr. Johnnes van der Loo is a director with the hospitals' research Institute.

"We have investigators come to us for a particular clinical trial being a cancer treatment or treatment for a neurological disease. And we manufacture that for that specific trial," she said.